India’s vaccination programme for minors

News Today (28.12.2021)

Mr. Modi’s announcement came minutes after an approval by the Drugs Controller General of India for Covaxin to be used by those over 12 years. This makes it the second Indian vaccine after ZyCoV-D, a DNA plasmid vaccine, to be approved for those above 12. ZyCoV-D, by Zydus Cadilla, is a three-dose combination whereas Covaxin by Bharat Biotech is a two-dose vaccine to be administered four weeks apart. A major difference is that ZyCoV-D inspite of being cleared in late August is not available in the market whereas Covaxin has been around for nearly a year. The company also says that being an inactivated whole virion vaccine, the dosage for children is the same as those for adults. (Read More)

Bookmark

Be the first to comment

Leave a Reply

Your email address will not be published.


*